• S1 Episode 6: Emerging and Novel Therapeutics in the Management of Psoriatic Arthritis

  • Apr 18 2022
  • Length: 21 mins
  • Podcast

S1 Episode 6: Emerging and Novel Therapeutics in the Management of Psoriatic Arthritis cover art

S1 Episode 6: Emerging and Novel Therapeutics in the Management of Psoriatic Arthritis

  • Summary

  • Elaine Husni, MD, MPH, and Ana-Maria Orbai, MD, MHS, discuss the emerging and novel therapeutics in psoriatic arthritis and the impact that they will have on their patients.

    Relevant disclosures can be found with the episode show notes on Medscape.com (https://www.medscape.com/viewarticle/959157). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

    Resources

    2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis https://www.rheumatology.org/Portals/0/Files/PsA-Guideline-2018.pdf

    EULAR Recommendations for the Management of Psoriatic Arthritis With Pharmacological Therapies: 2019 Update https://ard.bmj.com/content/79/6/700.1

    Treatment Guidelines in Psoriatic Arthritis https://academic.oup.com/rheumatology/article/59/Supplement_1/i37/5802853

    Bimekizumab in Patients with Active Psoriatic Arthritis: Results From a 48-Week, Randomised, Double-Blind, Placebo-Controlled, Dose-Ranging Phase 2b Trial https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)33161-7/fulltext

    Show More Show Less

What listeners say about S1 Episode 6: Emerging and Novel Therapeutics in the Management of Psoriatic Arthritis

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.